What ●●●●●●●●●●●●ns have you got? ●●●●●●te ●●●●●●se cost India's ●●●●●● move is a blow for GSK, which had cut ●●●●●●of Tykerb by a third in the ●●●●●●y as part of a ●●●●●●●●●●●●ing ●●●●●●mme ●●●●●●ed to make key drugs more ●●●●●●able ●●●●●●ain ●●●●●●ng ●●●●●●s.
